1. Home
  2. VTIX vs PLRX Comparison

VTIX vs PLRX Comparison

Compare VTIX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtuix Holdings Inc. Class A Common Stock

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$1.51

Market Cap

83.9M

Sector

Technology

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

68.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTIX
PLRX
Founded
2013
2015
Country
United States
United States
Employees
39
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.9M
68.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VTIX
PLRX
Price
$1.51
$1.06
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.67
AVG Volume (30 Days)
690.1K
690.9K
Earning Date
08-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.45
$1.05
52 Week High
$9.00
$1.95

Technical Indicators

Market Signals
Indicator
VTIX
PLRX
Relative Strength Index (RSI) 28.92 39.58
Support Level N/A N/A
Resistance Level $4.51 $1.37
Average True Range (ATR) 0.36 0.04
MACD -0.11 -0.00
Stochastic Oscillator 6.85 9.09

Price Performance

Historical Comparison
VTIX
PLRX

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc pioneers movement in AI-generated worlds, both imaginary and real. The company is the creator of Omni, a brand of omni-directional treadmills that enable users to walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. Its technology operates at the intersection of gaming, fitness, and enterprise VR. Its products include Omni Pro, Omni Arena, and Omni One. Its business integrates a consumer and enterprise VR hardware platform anchored by its flagship Omni One product with a defense-oriented simulation system, Virtual Terrain Walk (VTW), targeting next-generation immersive mission planning.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: